(Nasdaq: VCYT), a leading cancer diagnostics company, today announced results from the ENZAMET trial presented at the 2026 ASCO Annual Meeting. The analysis demonstrates that the Decipher Prostate ...
More than 15 abstracts showcase how the Veracyte Diagnostics Platform is advancing urologic cancer care with decisions guided by Decipher Prostate and Bladder tests SOUTH SAN FRANCISCO, ...
Confused about prostate cancer screening? Discover how the PSA test, modern MRI scans, and early detection can help you make ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results